Recombinant multi-species GRB2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GRB2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene binds the epidermal growth factor receptor and contains one SH2 domain and two SH3 domains. Its two SH3 domains direct complex formation with proline-rich regions of other proteins, and its SH2 domain binds tyrosine phosphorylated sequences. This gene is similar to the Sem5 gene of C.elegans, which is involved in the signal transduction pathway. Two alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
The Alternative Names of target: ASH,Adapter protein GRB2,Ash,Ash-psi,EGFRBP-GRB2,GRB2,Grb2,Grb3-3,Growth factor receptor-bound protein 2,MST084,MSTP084,NCKAP2,Protein Ash,SH2/SH3 adapter GRB2
Go
to GRB2 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP7736-Ag-1/ GM-Tg-hg-IP7736-Ag-2 | Human GRB2 protein | Human |
| GM-Tg-rg-IP7736-Ag-1/ GM-Tg-rg-IP7736-Ag-2 | Rat GRB2 protein | Rat |
| GM-Tg-mg-IP7736-Ag-1/ GM-Tg-mg-IP7736-Ag-2 | Mouse GRB2 protein | Mouse |
| GM-Tg-cynog-IP7736-Ag-1/ GM-Tg-cynog-IP7736-Ag-2 | Cynomolgus/Rhesus macaque GRB2 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP7736-Ag-1/ GM-Tg-felg-IP7736-Ag-2 | Feline GRB2 protein | Feline |
| GM-Tg-cang-IP7736-Ag-1/ GM-Tg-cang-IP7736-Ag-2 | Canine GRB2 protein | Canine |
| GM-Tg-bovg-IP7736-Ag-1/ GM-Tg-bovg-IP7736-Ag-2 | Bovine GRB2 protein | Bovine |
| GM-Tg-equg-IP7736-Ag-1/ GM-Tg-equg-IP7736-Ag-2 | Equine GRB2 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP7736-Ag-1/ GM-Tg-hg-IP7736-Ag-2;
GM-Tg-rg-IP7736-Ag-1/ GM-Tg-rg-IP7736-Ag-2;
GM-Tg-mg-IP7736-Ag-1/ GM-Tg-mg-IP7736-Ag-2; GM-Tg-cynog-IP7736-Ag-1/ GM-Tg-cynog-IP7736-Ag-2; GM-Tg-felg-IP7736-Ag-1/ GM-Tg-felg-IP7736-Ag-2; GM-Tg-cang-IP7736-Ag-1/ GM-Tg-cang-IP7736-Ag-2; GM-Tg-bovg-IP7736-Ag-1/ GM-Tg-bovg-IP7736-Ag-2; GM-Tg-equg-IP7736-Ag-1/ GM-Tg-equg-IP7736-Ag-2 |
| Products Name | GRB2 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | GRB2 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GRB2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.